Michael A. London is one of the founding partners in the law firm of Douglas & London. Mr. London was born in New York, New York. He obtained a Bachelor of Arts Degree from the University of Miami, in Coral Gables, Florida, and a Juris Doctorate Degree from Brooklyn Law School in New York. Mr. London is admitted and licensed to practice law in the State of New York and the State of New Jersey, as well as in the United States District Courts for the Eastern District, Southern District, and Western District of New York, as well as the District of New Jersey. He is also admitted to practice in the Court of Federal Claims in Washington, D.C.
Since obtaining his law degree, he has devoted his entire career to always representing injury victims and consumers, primarily in mass tort settings. Formerly a partner at another national plaintiffs’ law firm, his practice area in the law has always focused on, and continues to focus on, products liability and complex litigation with an emphasis in pharmaceutical litigation.
Mr. London is well known in the products liability and pharmaceutical and medical device areas of the law as one of the nations most skilled attorneys. The firm’s Verdicts and Settlements are just one measure of the success. Another measure is that he has been appointed by numerous judges across the country to serve on various steering committees in some of the country’s largest civil cases over the past 15 years. Specifically, he has been appointed to serve in a lead counsel or liaison counsel role in the following national cases:
■ Vice-chairman of Plaintiff Steering Committee – In re: Zyprexa Products Liability Litigation, MDL-1596, pending before the Honorable Jack B. Weinstein in the United States District Court for the Eastern District of New York. The result of this case was a $690 million settlement on behalf of approximately 8,000 claimants.
■ Co-Lead counsel of Plaintiff Steering Committee – In re: Yasmin and Yaz (Drospirenone) Marketing Sales Practice and Products Liability Litigation MDL-2100, pending before the Honorable David R. Herndon in the United States District Court for the Southern District of Illinois. This matter is still pending.
■ Federal liaison counsel and Plaintiff Executive Committee Member – In re: Ortho Evra Products Liability Litigation, MDL-1742, pending before the Honorable David S. Katz in the United States District Court for the Northern District of Ohio. The result of this case was that that over 2,000 claimants’ cases resolved under terms of confidentiality.
■ Co-lead counsel and liaison counsel for Plaintiff Steering Committee – In re: Bayer Corp Combination Aspirin Products Marketing and Sales Practice Litigation, MDL-2023, pending before the Honorable Brian M. Cogan in the United States District Court for the Eastern District of New York. This matter is still pending.
■ Co-liaison counsel for all Plaintiffs – In re Levaquin Litigation, centralized and consolidated litigation pending before the Honorable Carol E. Higbee in the Superior Court of New Jersey, Atlantic County. The result of this case was that that over 400 claimants’ cases resolved under terms of confidentiality.
Mr. London has also been asked to serve on Steering Committees in many other cases. While these appointments were not as lead counsel, they still reflect his extensive experience in complex pharmaceutical and class action cases:
■ Plaintiff Steering Committee, Member – In re: Composix Kugel Hernia Repair Patch Litigation, MDL-1842, pending before the Honorable Mary M. Lisi in the United States District Court of Rhode Island.
■ Plaintiff Steering Committee, Member – In re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL-2272, pending before the Honorable Rebecca R. Pallmeyer in the United States District Court for the Northern District of Illinois.
■ Plaintiff Steering Committee, Member, – In re: Heparin Products Liability Litigation, MDL-1953, pending before the Honorable James G. Carr in the United States District Court for the Northern District of Ohio.
■ Plaintiff Steering Committee, Member – In re: Denture Cream Products Liability Litigation, MDL-2051, pending before the Honorable Cecelia M. Altonaga in the United States District Court for the Southern District of Florida.
■ Plaintiff Steering Committee, Member – In re: DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation, MDL-2197, pending before the Honorable David S. Katz in the United States District Court for the Northern District of Ohio.
■ Plaintiff Steering Committee, Member, – In re: Light Cigarettes Marketing and Sales Practices Litigation, MDL-2068, pending before the Honorable John A. Woodcock, Jr. in the United States District Court for the District of Maine.
■ Plaintiff Steering Committee, Member – In re: Imagitas Inc. Drivers’ Privacy Protection Act Litigation, MDL-1828, pending before the Honorable Timothy J. Corrigan, in the United States District Court for the Middle District of Florida.
■ Plaintiff Steering Committee, Member – In re: Bextra/Celebrex Products Liability Litigation, pending before the Honorable Shirley Kornreich, in the New York State Supreme Court.
In addition, he was appointed to the Objectors’ Steering Committee to represent individual smokers with personal injury claims against Liggett & Myers in its proposed class action; he was co-counsel in one of the first national Thimerosal class action.
Not only has he held Court-appointed Steering Committee, but he has been involved in other complex litigation in various committee roles including discovery committees, expert committees, law and briefing committees, and class action committees. In addition, before founding Douglas & London, P.C., he was always actively in litigating pharmaceutical cases, including active participation in the silicone breast implant litigation, both in the federal courts part of MDL-926, before the Honorable Samuel C. Pointer, Jr., and in the Dow Corning bankruptcy proceeding, where his former law firm held Steering Committee roles in both forums. He also participated in and litigated the Parlodel drug products liability cases.
Mr. London has also represented hundreds of women exposed, in utero, to the drug Diethylstilbestrol (“DES”) in litigation pending before the Honorable Jack B. Weinstein. He has represented and continues to represent children and families who were victims of the medical device/procedure Chorionic Villi Sampling, as well as many other toxic and mass torts for which formal plaintiff steering committees were not established. He has used this knowledge and vast experience in representing young children today who are still being exposed to dangerous medications while in utero, due to drug companies’ failure to test for or warn of these dangerous side effects. Examples of these dangerous medications are:
- Antidepressants such as Paxil, Zoloft, Prozac, Lexapro, Celexa, Wellbutrin and Effexor (SSRIs and SNRIs);
- Depakote (anti-seizure medication);
- Topamax (anti-seizure medication);
- Proton pump inhibitors such as Nexium, Prilosec, Zegerid, Prevacid, Protonix, or AcipHex (digestive track medication)
In addition to the above, Mr. London has extensive experience with heart device litigation where he haw represented hundreds of injured clients across the country in the recent implantable defibrillator litigations (e.g. Guidant implantable defibrillators, Medtronic implantable defibrillators, and Medtronic Sprint Fidelis Leads, MDL-1708, MDL-1726, and MDL-1905, respectively). He and his firm also represented over 500 people who were injured by the Cox-2 inhibitor medications Vioxx, Bextra, and Celebrex.
Mr. London has served as trial counsel in multiple tobacco trials, including the first successful verdict against the tobacco industry in the state of New York, when he and Firm partner Gary Douglas secured a $20 million plus verdict for the widow of a former smoker. Mr. London previously served as co-trial counsel in the first two tobacco cases to be tried in the State of New York – both in the year 2000. Mr. London has also been actively involved in prosecution and appellate issues in personal injury tobacco litigation across the country, including in San Francisco, Missouri, and Florida. Mr. London was co-trial counsel in the very first Norplant products liability trial in the State of New York – and shortly after the verdict in his trial, a national settlement of over $40 million was reached.
Mr. London is an active member in the following legal associations: Board of Directors New York State Trial Lawyers Association (NYSTLA); Sustaining Member American Association of Justice (AAJ), f/k/a ATLA; Member of Public Justice (America’s Public Interest law firm); and Member the Tobacco Trial Lawyers Association (TTLA). He serves on the President’s Advisory Council at Brooklyn Law School and has been asked to serves as on the University of Miami Dean of Arts & Sciences Visiting Committee. He has been asked and invited to lecture to attorneys on many types of cases that he has handled, as well as on specific topics such as preemption, virtually all aspects of mass tort litigations and specific cases, medical malpractice and jury selection in various types of cases. He has appeared on CNN, MSNBC, NBC, ABC, in the New York Times, in New York Magazine, Forbes, as well as in many other local New York and regional papers and other publications across the country. Additionally, he has written numerous articles for publication in legal journals on such topics of vaccine use, the Learned Intermediary Doctrine, the Harvard University Medical Malpractice Study, jury selection in products liability cases, mercury exposure, youth smoking, and light cigarettes litigation, generally.